|
|
|
Volumn 14, Issue 2, 1996, Pages
|
|
Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database
a
|
|
Author keywords
Adverse effects; Calcium antagonists; Hypertension; Lacidipine; Morbidity; Mortality
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
LACIDIPINE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
EDEMA;
FEMALE;
FLUSHING;
HEADACHE;
HEART INFARCTION;
HEART PALPITATION;
HEART RATE;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
MORBIDITY;
MORTALITY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
ADULT;
AGED;
CALCIUM CHANNEL BLOCKERS;
CLINICAL TRIALS, PHASE III;
CLINICAL TRIALS, PHASE IV;
DIHYDROPYRIDINES;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 0029905544
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (5)
|
